Statistics for Bicycle Therapeutics Ltd (id:7945 BCYC)

Valuation metrics

Market cap

1.41B

Enterprise value

624.74M

Trailing P/E (ttm)

-4.01

Forward P/E

-5.76

PEG ratio

-5.76

Price/Sales (ttm)

38.29

Price/Book (mrq)

1.70

Enterprise Value/Revenue

16.93

Enterprise Value/EBITDA

-3.30

Overview

Shares outstanding

47.55M

Float

Shares short

3.27M

% Held by insiders

0.01%

% Held by institutions

0.92%

Average volume (10 days)

338.70K

Average volume (90 days)

Price summary

52-Week low

13.31

52-Week high

28.67

52-Week change

32.02%

Beta

0.89

50-Day moving average

24.62

200-Day moving average

23.16

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,385.87%

Operational effectiveness

Return on assets

-15.02%

Return on equity

-26.67%

Income statement

Revenue (ttm)

0.72

Revenue per share (ttm)

0.72

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-189,320,000.00

Net income to common (ttm)

-166,276,000.00

Diluted EPS (ttm)

-3.28

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

890.86M

Total cash per share (mrq)

12.90

Total debt (mrq)

11.09M

Total Debt/Equity (mrq)

1.33

Current ratio (mrq)

1.71K%

Book value per share (mrq)

12.04

Cash flow

Cash flow statement

-202,616,000.00

Levered free cash flow (LFCF)

-141,178,752.00